"We are talking about the production of several hundred thousand doses per month. The states of the Persian Gulf are now showing the greatest interest in the vaccine," Ignatiev said.
The press service of R-Pharm clarified that the R-Covi vaccine, produced under the license of Oxford University and AstraZeneca, will be sent for export exclusively. The drug will not enter civil circulation in Russia, and therefore it does not require a certificate of registration.
As it was reported, the Russian Healthcare Ministry has officially registered Sputnik Light vaccine from coronavirus on May 6.
In late February, the Russian fund of direct investments submitted an appeal for registration of the drug, and the trials on volunteers began. On March 29, the Russian Healthcare Ministry started the registration procedure.
Russia had previously registered three vaccines against Covid-19 - Sputnik V, EpiVacCorona, and CoviVac.